SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-23-000611
Filing Date
2023-02-27
Accepted
2023-02-27 16:05:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d12927020_02242023.htm SC 13D 306603
2 JOINT FILING AGREEMENT ex991to13d12927020_02242023.htm EX-99.1 18191
  Complete submission text file 0000921895-23-000611.txt   326388
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91228 | Film No.: 23674732
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1055B POWERS PLACE ALPHARETTA GA 30009
Business Address 1055B POWERS PLACE ALPHARETTA GA 30009 646-844-0037
Velan Capital Investment Management LP (Filed by) CIK: 0001848809 (see all company filings)

IRS No.: 844706623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D